These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3936866)

  • 41. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial.
    Eijkhout HW; van Der Meer JW; Kallenberg CG; Weening RS; van Dissel JT; Sanders LA; Strengers PF; Nienhuis H; Schellekens PT;
    Ann Intern Med; 2001 Aug; 135(3):165-74. PubMed ID: 11487483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Regulation of autoreactivity by the idiotypic network and therapeutic modulation of autoimmunity by polyvalent intravenous immunoglobulins (IgIV)].
    Lacroix-Desmazes S; Kaveri S; Kazatchkine MD
    Rev Neurol (Paris); 1996 May; 152(5):349-54. PubMed ID: 8881428
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial.
    ; Gale RP; Chapel HM; Bunch C; Rai KR; Foon K; Courter SG; Tait D
    N Engl J Med; 1988 Oct; 319(14):902-7. PubMed ID: 2901668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and investigational considerations for the use of IGIV therapy.
    Ballow M
    Am J Health Syst Pharm; 2005 Aug; 62(16 Suppl 3):S12-8; quiz S19-21. PubMed ID: 16100383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of intravenous immunoglobulin (Sandoglobulin) in neonates.
    Weisman LE; Fischer GW; Hemming VG; Peck CC
    Pediatr Infect Dis; 1986; 5(3 Suppl):S185-8. PubMed ID: 3520504
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized prospective clinical trial to determine the efficacy of interferon-gamma in severely injured patients.
    Polk HC; Cheadle WG; Livingston DH; Rodriguez JL; Starko KM; Izu AE; Jaffe HS; Sonnenfeld G
    Am J Surg; 1992 Feb; 163(2):191-6. PubMed ID: 1739172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Demonstration of safety of intravenous immunoglobulin in geriatric patients in a long-term, placebo-controlled study of Alzheimer's disease.
    Gelmont D; Thomas RG; Britt J; Dyck-Jones JA; Doralt J; Fritsch S; Brewer JB; Rissman RA; Aisen P
    Alzheimers Dement (N Y); 2016 Jun; 2(2):131-139. PubMed ID: 29067300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.
    Daoud YJ; Amin KG
    Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A prospective, double-blind, placebo-controlled trial of i.v. immunoglobulin and trimethoprim-sulfamethoxazole in children with recurrent respiratory tract infections.
    Nydahl-Persson K; Petterson A; Fasth A
    Acta Paediatr; 1995 Sep; 84(9):1007-9. PubMed ID: 8652950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients.
    Abraham E; Laterre PF; Garbino J; Pingleton S; Butler T; Dugernier T; Margolis B; Kudsk K; Zimmerli W; Anderson P; Reynaert M; Lew D; Lesslauer W; Passe S; Cooper P; Burdeska A; Modi M; Leighton A; Salgo M; Van der Auwera P;
    Crit Care Med; 2001 Mar; 29(3):503-10. PubMed ID: 11373411
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of intravenous gammaglobulin for immunoglobulin G subclass and/or antibody deficiency in adults.
    Abdou NI; Greenwell CA; Mehta R; Narra M; Hester JD; Halsey JF
    Int Arch Allergy Immunol; 2009; 149(3):267-74. PubMed ID: 19218820
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma.
    Sirvent JM; Torres A; El-Ebiary M; Castro P; de Batlle J; Bonet A
    Am J Respir Crit Care Med; 1997 May; 155(5):1729-34. PubMed ID: 9154884
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of intravenous immunoglobulin therapy in autoimmune blistering diseases.
    Ahmed AR
    Int Immunopharmacol; 2006 Apr; 6(4):557-78. PubMed ID: 16504919
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monitoring of two intravenous immunoglobulin. Preparations for immunoglobulin G subclasses and specific antibodies to bacterial surface antigens and relation with their levels in treated immunodeficient patients.
    Lamari F; Karamanos NK; Papadopoulou-Alataki E; Kanakoudi-Tsakalidou F; Dimitracopoulos G; Anastassiou ED
    J Pharm Biomed Anal; 2000 Jul; 22(6):1029-36. PubMed ID: 10857572
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new liquid, intravenous immunoglobulin product (IGIV 10%) highly purified by a state-of-the-art process.
    Teschner W; Butterweck HA; Auer W; Muchitsch EM; Weber A; Liu SL; Wah PS; Schwarz HP
    Vox Sang; 2007 Jan; 92(1):42-55. PubMed ID: 17181590
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selective decontamination of the digestive tract in multiple trauma patients. A prospective double-blind, randomized, placebo-controlled study.
    Quinio B; Albanèse J; Bues-Charbit M; Viviand X; Martin C
    Chest; 1996 Mar; 109(3):765-72. PubMed ID: 8617089
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of intravenous immunoglobulin: a systematic review.
    Koleba T; Ensom MH
    Pharmacotherapy; 2006 Jun; 26(6):813-27. PubMed ID: 16716135
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Perioperative antibiotic use in high-risk penetrating hollow viscus injury: a prospective randomized, double-blind, placebo-control trial of 24 hours versus 5 days.
    Kirton OC; O'Neill PA; Kestner M; Tortella BJ
    J Trauma; 2000 Nov; 49(5):822-32. PubMed ID: 11086771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit.
    Verwaest C; Verhaegen J; Ferdinande P; Schetz M; Van den Berghe G; Verbist L; Lauwers P
    Crit Care Med; 1997 Jan; 25(1):63-71. PubMed ID: 8989178
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective decontamination of the digestive tract in multiple trauma patients--is there a role? Results of a prospective, double-blind, randomized trial.
    Hammond JM; Potgieter PD; Saunders GL
    Crit Care Med; 1994 Jan; 22(1):33-9. PubMed ID: 8124970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.